- Home
- Publications
- Publication Search
- Publication Details
Title
The IL-1 family in tumorigenesis and antitumor immunity
Authors
Keywords
IL-1, IL-18, IL-33, IL-36, Tumorigenesis, Anti-tumor immune response
Journal
SEMINARS IN CANCER BIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-05-14
DOI
10.1016/j.semcancer.2022.05.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
- (2021) Min Yang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Nuclear IL‐33/SMAD signaling axis promotes cancer development in chronic inflammation
- (2021) Jong Ho Park et al. EMBO JOURNAL
- A gene–environment-induced epigenetic program initiates tumorigenesis
- (2021) Direna Alonso-Curbelo et al. NATURE
- Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor
- (2021) James K. Fields et al. Frontiers in Immunology
- Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
- (2020) Shipra Das et al. CANCER RESEARCH
- Enteric Nervous System-Derived IL-18 Orchestrates Mucosal Barrier Immunity
- (2020) Abigail Jarret et al. CELL
- Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF
- (2020) Michael Delacher et al. IMMUNITY
- ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
- (2020) John Alec Moral et al. NATURE
- Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s
- (2020) Marek Wagner et al. Cell Reports
- IL33 Is a Key Driver of Treatment Resistance of Cancer
- (2020) Chie Kudo-Saito et al. CANCER RESEARCH
- IL-18 immunoadjuvanted xenogeneic canine MMP-7 DNA vaccine overcomes immune tolerance and supresses the growth of murine mammary tumor
- (2020) Pavan Kumar Yadav et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial
- (2020) Gabriel I. Nistor et al. Journal of Translational Medicine
- Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response
- (2020) Xinghuo Li et al. LEUKEMIA
- IL1α Antagonizes IL1β and Promotes Adaptive Immune Rejection of Malignant Tumors
- (2020) Tian Tian et al. Cancer Immunology Research
- Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy
- (2020) Dylan J. Drakes et al. Cancer Immunology Research
- IL36 Cooperates With Anti-CTLA-4 mAbs to Facilitate Antitumor Immune Responses
- (2020) Qiuxia Qu et al. Frontiers in Immunology
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung
- (2020) Martijn J. Schuijs et al. NATURE IMMUNOLOGY
- Gasdermin-D-dependent IL-1α release from microglia promotes protective immunity during chronic Toxoplasma gondii infection
- (2020) Samantha J. Batista et al. Nature Communications
- Fibroblast-derived IL-33 facilitates breast cancer metastasis by modifying the immune microenvironment and driving type-2 immunity
- (2020) Ophir Shani et al. CANCER RESEARCH
- Inhibition of IL-1β by canakinumab may be effective against diverse molecular subtypes of lung cancer: an exploratory analysis of the CANTOS trial
- (2020) Connie C Wong et al. CANCER RESEARCH
- Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
- (2020) Astrid De Boeck et al. Nature Communications
- Anti-cancer effect of engineered recombinant interleukin 18
- (2020) Jirakrit Saetang et al. Advances in Clinical and Experimental Medicine
- Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy
- (2020) Lujun Chen et al. Cancer Immunology Research
- Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells
- (2019) Locke D. Uppendahl et al. GYNECOLOGIC ONCOLOGY
- Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
- (2019) Susannah L. Hewitt et al. Science Translational Medicine
- Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
- (2019) Clémence Hollande et al. NATURE IMMUNOLOGY
- Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation
- (2019) Mercedes Segovia et al. CANCER CELL
- The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
- (2019) Eva Pastille et al. Mucosal Immunology
- Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer
- (2019) Glauben Landskron et al. Frontiers in Immunology
- High Serum Levels of Interleukin-18 Are Associated With Worse Outcomes in Patients With Breast Cancer
- (2019) NATSUKO INOUE et al. ANTICANCER RESEARCH
- Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells
- (2019) Ping-Hsien Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
- (2019) Charles S. Tannenbaum et al. Cancer Immunology Research
- IL-36β Promotes CD8+ T Cell Activation and Antitumor Immune Responses by Activating mTORC1
- (2019) Xin Zhao et al. Frontiers in Immunology
- Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model
- (2019) Yulong Xia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MAIT cells are imprinted by the microbiota in early life and promote tissue repair
- (2019) Michael G. Constantinides et al. SCIENCE
- Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis
- (2019) Yi-Ling Chen et al. Science Translational Medicine
- Biology of IL-36 Signaling and Its Role in Systemic Inflammatory Diseases
- (2019) Zhi-Chao Yuan et al. Frontiers in Immunology
- IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing
- (2019) Sara Andreone et al. Cancers
- IL‐18R‐dependent and independent pathways account for IL‐18‐enhanced antitumor ability of CAR‐T cells
- (2019) Yong Huang et al. FASEB JOURNAL
- The balance of serum IL-18/IL-37 levels is disrupted during the development of oral squamous cell carcinoma
- (2019) Liang Ding et al. SURGICAL ONCOLOGY-OXFORD
- IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development
- (2019) Amy Li et al. Cell Reports
- A comprehensive pathway map of IL-18-mediated signalling
- (2019) D.A.B Rex et al. Journal of Cell Communication and Signaling
- A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma
- (2018) Marta Epeldegui et al. AIDS
- Tumor–Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
- (2018) Daoxiang Zhang et al. CANCER RESEARCH
- Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy
- (2018) Hiroaki Senju et al. International Journal of Biological Sciences
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
- (2018) Margherita Norelli et al. NATURE MEDICINE
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System
- (2018) Mauro P. Avanzi et al. Cell Reports
- Adaptive Natural Killer Cells Integrate Interleukin-18 during Target-Cell Encounter
- (2018) Quirin Hammer et al. Frontiers in Immunology
- Myeloid-derived suppressor cell accumulation in renal cell carcinoma is correlated with CCL2, IL-17 and IL-18 expression in blood and tumors
- (2018) XIAODONG GUAN et al. Advances in Clinical and Experimental Medicine
- Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells
- (2018) Jintong Chen et al. Frontiers in Immunology
- Urinary cytokine profile to predict response to intravesical BCG with or without HS-410 therapy in patients with non-muscle invasive bladder cancer
- (2018) Amirali Salmasi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer
- (2018) Aliyah M. Weinstein et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells
- (2018) Ning Liu et al. Cellular & Molecular Immunology
- Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma
- (2018) Lihui Zhuang et al. Hepatology International
- IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4+ and CD8+ T Cell Responses in Hepatocellular Carcinoma
- (2018) Ziqi Jin et al. JOURNAL OF IMMUNOLOGY
- Type 2 Innate Lymphoid Cells Impede IL-33–Mediated Tumor Suppression
- (2018) Alan Long et al. JOURNAL OF IMMUNOLOGY
- Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis
- (2018) Yichao Chen et al. Nanomedicine-Nanotechnology Biology and Medicine
- Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery
- (2018) Minako Ito et al. NATURE
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-36γ has proinflammatory effects on human endothelial cells
- (2017) Charlie Bridgewood et al. EXPERIMENTAL DERMATOLOGY
- Regulation and function of interleukin-36 cytokines
- (2017) Esen Yonca Bassoy et al. IMMUNOLOGICAL REVIEWS
- Interleukin-18: Biological properties and role in disease pathogenesis
- (2017) Gilles Kaplanski IMMUNOLOGICAL REVIEWS
- Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
- (2017) Corinne Cayrol et al. IMMUNOLOGICAL REVIEWS
- Cutting Edge: Distinct Regulatory Mechanisms Control Proinflammatory Cytokines IL-18 and IL-1β
- (2017) Qifan Zhu et al. JOURNAL OF IMMUNOLOGY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- CAR T Cells Releasing IL-18 Convert to T-Bet high FoxO1 low Effectors that Exhibit Augmented Activity against Advanced Solid Tumors
- (2017) Markus Chmielewski et al. Cell Reports
- Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumors
- (2017) A. Kunert et al. OncoImmunology
- Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment
- (2017) Aliyah M. Weinstein et al. OncoImmunology
- Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma
- (2016) John A. Lust et al. AMERICAN JOURNAL OF HEMATOLOGY
- Caspase-1 Inflammasome Activation Mediates Homocysteine-Induced Pyrop-Apoptosis in Endothelial CellsNovelty and Significance
- (2016) Hang Xi et al. CIRCULATION RESEARCH
- Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines
- (2016) Damien Dietrich et al. CYTOKINE
- IL-33 regulates the IgA-microbiota axis to restrain IL-1α–dependent colitis and tumorigenesis
- (2016) Ankit Malik et al. JOURNAL OF CLINICAL INVESTIGATION
- Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
- (2016) Donye Dominguez et al. JOURNAL OF IMMUNOLOGY
- Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth
- (2016) Juyang Kim et al. JOURNAL OF IMMUNOLOGY
- IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis
- (2016) Yu Zhang et al. MOLECULAR CARCINOGENESIS
- Interleukin 1α and the inflammatory process
- (2016) Nelson C Di Paolo et al. NATURE IMMUNOLOGY
- Immunologic Function and Molecular Insight of Recombinant Interleukin-18
- (2016) Jirakrit Saetang et al. PLoS One
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia
- (2016) Lei Qin et al. Oncotarget
- IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses
- (2015) Xuefeng Wang et al. CANCER CELL
- Persistent HPV16/18 infection in Indian women with the A-allele (rs6457617) of HLA-DQB1 and T-allele (rs16944) of IL-1β −511 is associated with development of cervical carcinoma
- (2015) Sankhadeep Dutta et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis
- (2015) Naomi Tsurutani et al. JOURNAL OF IMMUNOLOGY
- IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction
- (2015) Claudia A Nold-Petry et al. NATURE IMMUNOLOGY
- Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells
- (2015) Rafael Carretero et al. NATURE IMMUNOLOGY
- IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance
- (2015) XIAO-LEI YE et al. ONCOLOGY REPORTS
- IL-33 activates tumor stroma to promote intestinal polyposis
- (2015) Rebecca L. Maywald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells
- (2015) Peng Xiao et al. OncoImmunology
- Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
- (2015) Ole Audun Werner Haabeth et al. OncoImmunology
- Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity
- (2014) Daniel O. Villarreal et al. CANCER RESEARCH
- Interleukin 1β and Interleukin 1 Receptor Antagonist Gene Polymorphisms and Cervical Cancer
- (2014) Shimu Wu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin
- (2014) A. M. Foster et al. JOURNAL OF IMMUNOLOGY
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
- (2014) David S Hong et al. LANCET ONCOLOGY
- Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ
- (2014) Lei Wang et al. MEDICAL ONCOLOGY
- Eosinophils and Cancer
- (2014) B. P. Davis et al. Cancer Immunology Research
- Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
- (2013) Kun Gao et al. CANCER LETTERS
- A Special Population of Regulatory T Cells Potentiates Muscle Repair
- (2013) Dalia Burzyn et al. CELL
- Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation
- (2013) Yue Zheng et al. IMMUNITY
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells
- (2013) Shlomo Z. Ben-Sasson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Different Members of the IL-1 Family Come Out in Different Ways: DAMPs vs. Cytokines?
- (2013) Sonia Carta et al. Frontiers in Immunology
- Interleukin-18 and IL-18 Binding Protein
- (2013) Charles A. Dinarello et al. Frontiers in Immunology
- IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells
- (2012) S. Vigne et al. BLOOD
- IL-36 in psoriasis
- (2012) JE Towne et al. CURRENT OPINION IN PHARMACOLOGY
- IL-36γ/IL-1F9, an Innate T-bet Target in Myeloid Cells
- (2012) Malte Bachmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production
- (2012) Guangying Du et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori–specific immune tolerance, and asthma protection
- (2012) Mathias Oertli et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-1R–MyD88 signaling in keratinocyte transformation and carcinogenesis
- (2012) Christophe Cataisson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Macrophage plasticity and polarization in tissue repair and remodelling
- (2012) Alberto Mantovani et al. JOURNAL OF PATHOLOGY
- IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal
- (2012) Hugo Sousa et al. MOLECULAR BIOLOGY REPORTS
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
- (2012) F. L. van de Veerdonk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The transcription of the alarmin cytokine interleukin-1 alpha is controlled by hypoxia inducible factors 1 and 2 alpha in hypoxic cells
- (2012) Peleg Rider et al. Frontiers in Immunology
- IL-33/ST2 axis in innate and acquired immunity to tumors
- (2012) Ivan P. Jovanovic et al. OncoImmunology
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+T cells
- (2011) Qianting Yang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9
- (2011) Shilla Mutamba et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor Promotion via Injury- and Death-Induced Inflammation
- (2011) Ali Kuraishy et al. IMMUNITY
- Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C–511T polymorphism with cervical cancer risk in Egyptian women
- (2011) Magdy A. Al-Tahhan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- IL-33 Induces IL-9 Production in Human CD4+ T Cells and Basophils
- (2011) Lars Blom et al. PLoS One
- Inflammasomes: current understanding and open questions
- (2010) Franz Bauernfeind et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
- (2010) Rosalba Salcedo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation
- (2010) M. H. Zaki et al. JOURNAL OF IMMUNOLOGY
- Human Eosinophils Exert TNF- and Granzyme A-Mediated Tumoricidal Activity toward Colon Carcinoma Cells
- (2010) F. Legrand et al. JOURNAL OF IMMUNOLOGY
- IL-1 family nomenclature
- (2010) Charles Dinarello et al. NATURE IMMUNOLOGY
- IL-37 is a fundamental inhibitor of innate immunity
- (2010) Marcel F Nold et al. NATURE IMMUNOLOGY
- IL-1 pathways in inflammation and human diseases
- (2010) Cem Gabay et al. Nature Reviews Rheumatology
- Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
- (2010) Jun Hou et al. PLoS One
- Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate
- (2010) E. N. Arwert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction
- (2010) N. R. Blatner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential release of chromatin-bound IL-1 discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation
- (2010) I. Cohen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis
- (2009) Gaby Palmer et al. ARTHRITIS AND RHEUMATISM
- The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production
- (2009) Elvire Bourgeois et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Central Nervous System-Restricted Isoform of the Interleukin-1 Receptor Accessory Protein Modulates Neuronal Responses to Interleukin-1
- (2009) Dirk E. Smith et al. IMMUNITY
- The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress
- (2009) Luke A. J. O'Neill IMMUNOLOGICAL REVIEWS
- Circulating IL-1β levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women
- (2009) Nianfeng Qian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Host-Derived Interleukin-1 Is Important in Determining the Immunogenicity of 3-Methylcholantrene Tumor Cells
- (2009) M. Elkabets et al. JOURNAL OF IMMUNOLOGY
- The Essential Role of Single Ig IL-1 Receptor-Related Molecule/Toll IL-1R8 in Regulation of Th2 Immune Response
- (2009) K. Bulek et al. JOURNAL OF IMMUNOLOGY
- The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
- (2009) Luigi Franchi et al. NATURE IMMUNOLOGY
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
- (2009) S. Z. Ben-Sasson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic variants of interleukin-1RN and interleukin-1β genes and risk of cervical cancer
- (2008) H Singh et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis
- (2008) Toshiharu Sakurai et al. CANCER CELL
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
- (2008) Shuiping Tu et al. CANCER CELL
- Inflammation and cancer: The oncogene-driven connection
- (2008) Maria Grazia Borrello et al. CANCER LETTERS
- Prediction of Recurrence-Free Survival in Postoperative Non-Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression
- (2008) E.-S. Lee et al. CLINICAL CANCER RESEARCH
- Role of bone marrow-derived cells in experimental chronic pancreatitis
- (2008) F Marrache et al. GUT
- Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?
- (2008) Ron N. Apte et al. IMMUNOLOGICAL REVIEWS
- IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
- (2008) M. D. Smithgall et al. INTERNATIONAL IMMUNOLOGY
- Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens
- (2008) Maciej Lech et al. JOURNAL OF EXPERIMENTAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now